Latest UCLA's Jules Stein Eye Institute Stories
MARLBOROUGH, Mass., July 14, 2011 /PRNewswire/ -- Advanced Cell Technology, Inc.
If you had cancer and a genetic test could predict the risk of the tumor spreading aggressively, would you want to know â€“ even if no treatments existed to help you?
In findings that could lead to curing some forms of congenital blindness through gene therapy, researchers at UCLA have discovered that RPE65, a gene missing in infants born with the blinding disease Leber congenital amaurosis, is also a key enzyme in the visual cycle. The identity of this enzyme has long been a mystery to scientists.